Dr. Robert Lanford, PhD, is currently the Director of the Southwest National Primate Research Center, one of seven NIH National Primate Research Centers. He is a Scientist at the Texas Biomedical Research Institute and an Adjunct Professor at the University of Texas Health Science Center. Dr. Robert E. Lanford received a B.S. degree from the University of Texas at Arlington in 1974 and a Ph.D. in Virology from Baylor College of Medicine in 1979. He served as Assistant Professor at Baylor College of Medicine until 1984 when he moved to the Southwest Foundation for Biomedical Research (now Texas Biomedical Research Institute) to initiate programs on the use of nonhuman primates as models for human hepatitis infections. Dr. Lanford has published over 170 scientific papers and serves as a reviewer for several journals. His laboratory performs research on multiple hepatitis viruses HAV, HBV, HCV and GBV-B. One of the primary goals of his research program is to better understand the interactions of the virus with the host, and how these interactions influence either viral clearance or persistence and disease progression. His studies in the chimpanzee were the first to use total genome microarray analysis to examine viral-host interactions and the innate immune response to HCV. In collaboration with pharmaceutical companies, he has utilized the chimpanzee model of chronic HBV and HCV infections to evaluate efficacy of new antiviral therapies as the last preclinical step prior to human clinical trials. These studies contributed to the development of cocktails of antivirals that can now cure HCV infection in 12 weeks. Recently, Dr. Lanford has developed a primate model for liver cancer by the genetic engineering of primary baboon hepatocytes with activated baboon oncogenes and autologous transplantation of the cells to the liver of the immunocompetent hepatocyte donor. Efforts are ongoing in his laboratory to develop new nonhuman primate models for HBV research.
Professor of Political Science / SociologyBinghamton University, State University of New York
Sociology, Islam, islamic law, Conflict Resolution, Democratization, Politics
Scientific Program ManagerInternational Life Sciences Institute North America
scientific integrity, public-private partnerships, Scientific Project Management, Food Composition Databases
Dr. Larrick believes that scientific integrity is essential to developing sound science that improves society, and that the public and private sectors can and should work together on science and health issues of common interest. Dr. Larrick’s scientific expertise is in biochemical and molecular nutrition, and she leverages this knowledge to engage multi-sector scientists to advance food safety research and global food composition database development. In addition, Dr. Larrick leads ILSI North America’s work related to promoting integrity and transparency in science, managing conflicts of interest, and developing successful public-private research partnerships.
Senior Program ManagerInternational Life Sciences Institute North America
Nutrition, Nutrition & Nutrients, nutrition and public health, nutrition expert
Senior Program Manager with ILSI North America managing the programs of several Nutrition Science Committees and developing new concepts into larger scale programs. Nearly 20 years of experience in addressing emerging nutrition issues and application of evidence to policy development. Passionate about engaging stakeholders with diverse perspectives to facilitate dialogue and address issues of common concern to improve health. Previously served as Study Director for the Review of Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Food Packages at the National Academies’ Food and Nutrition Board. Registered dietitian nutritionist (RDN) with a Master of Science degree in nutrition.
Mark is the Queen's Lead of the £5M Medical Research Council-Cancer Research UK funded Stratified Medicine in Colorectal Cancer Consortium (S:CORT), a UK-wide consortium investigating novel precision medicine approaches in colorectal cancer(CRC). His international reputation in CRC was instrumental in his leading a Critical Gaps in Colorectal Cancer Research Initiative, recently published in the high impact factor journal Gut; this landmark publication has attracted significant global attention (his podcast had the most “hits” of any article in the journal) Mark is Queen's Lead of the Health Data Research UK Substantive Site, one of only 6 in the UK, which aims to drive innovative precision medicine and public health approaches through the use of Big Data. He is also national lead for Cancer Strategy for HDR-UK. Mark was co-chair of the Cancer Task Team of the Clinical Working Group of the Global Alliance for Genomics and Health (GA4GH), an international cooperative dedicated to effective and responsible sharing of genomic and clinical data. He has authored a number of key papers including a blueprint for cancer date sharing (published in Nature Medicine) and a road map/call to action for a Global Cancer Knowledge Network in the New England Journal of Medicine Mark has published over 180 papers in international peer review journals, including key papers in the highest impact journals (New Engl J Medicine, Lancet, Nature Medicine, Lancet Oncology, Cancer Discovery, Nature Comms, Gut etc). He is co-lead of an ambitious proposal to develop a Global Innovation Institute in Belfast which will include the One Health Innovation Centre (OHIC), the world’s first Health and Agri-Food Informatics Innovation Centre. Mark’s work has been recognised by a number of national/international awards including the Vander Molen Prize for Leukaemia Research, the Ely Lilly Prize, the St Lukes Medal for Cancer Research and the Graves Medal for Medical Research. He is frequently invited as a guest speaker to international conferences and sits on a number of high level boards/committees at European level including the European Alliance for Personalised Medicine, the Scientific Board of the European Cancer Patient Coalition and the European Cancer Organisation (ECCO) Oncopolicy Forum Mark has a strong commitment to patient-centred research/care and to addressing cancer inequalities. He was the architect of the European Cancer Patient's Bill of Rights (BoR), a catalyst for change and empowerment tool for cancer patients which he launched in the European Parliament on World Cancer Day 2014. The BoR has been adopted across Europe and led to the 70:35 Vision, 70% survival for all cancer patients in Europe by 2035 which was recently adopted by ECCO, the largest interdisciplinary cancer organisation in Europe. Mark’s advocacy work was instrumental in the recent decision to include boys in national UK HPV vaccination programmes. He is also committed to the provision of optimal pathology and laboratory medicine for citizens in resource-limited settings and was senior author of a recent paper in The Lancet as part of The Lancet Series on Pathology and Laboratory Medicine in Low- and Middle- Income Countries.
Dr. Ley joined LJI in 2007 as the founding Division Head of the Division of Inflammation Biology. Dr. Ley received his B.S. from Altkönigschule-Gymnasium, Kronberg, Germany in 1976. In 1982, he received his M.D. from the Julius-Maximilians-Universität, Würzburg, Germany. Dr. Ley began his postdoctoral training from 1983 to 1987 at the Freie Universität Berlin, Germany. From 1987 to 1989, Dr. Ley was a visiting research scientist at the University of California, San Diego and returned to Freie Universität Berlin until 1994, when he joined the faculty of the University of Virginia. From 2001-2007, he was director of the Robert M Berne Cardiovascular Research Center at the University of Virginia.
Dr. Christina Li received her medical degree from the Columbia College of Physicians and Surgeons. She completed her residency in general surgery at the University of Maryland and was also a research fellow at the Maryland Center for Videoscopic Surgery. She completed a fellowship in minimally invasive and bariatric surgery at the University of Pennsylvania. She has been performing bariatric surgery for LifeBridge Health since 2004 and is a founding member of Sinai Hospital's Bariatric Center for Excellence.
Steven K. Libutti, MD, FACS, was appointed as Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences in January 2017. In addition to his leadership roles within Rutgers University, Dr. Libutti also serves as Senior Vice President of Oncology Services for RWJBarnabas Health, further strengthening the university’s partnership with the healthcare system. He is also a Professor of Surgery at Rutgers Robert Wood Johnson Medical School and an Affiliated Distinguished Professor in Genetics at the Rutgers School of Arts and Sciences Department of Genetics. Most recently, Dr. Libutti served as Director for the Montefiore Einstein Center for Cancer Care in New York City and was a Professor and Vice Chairman of the Department of Surgery and Professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. A surgical oncologist, Dr. Libutti is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors. He is the immediate Past President of the American Association of Endocrine Surgeons. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas. The recipient of funding from the National Cancer Institute (NCI) for the past 20 years, Dr. Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment and blood vessel formation in tumors. He is studying tumor neovascular formation and the interaction between tumor cells, endothelial cells and the components of the tumor microenvironment including fibroblasts and cancer stem cells. His work also focuses on a better understanding of the tumor suppressor genes MEN1 and FILIP1L. After graduating magna cum laude from Harvard College, Dr. Libutti received his medical degree from the College of Physicians and Surgeons of Columbia University. He remained at Presbyterian Hospital in New York where he completed his residency in surgery, followed by a fellowship at the NCI in surgical oncology and endocrine surgery. He continued at the NCI where he became a tenured Senior Investigator and Chief of the Tumor Angiogenesis Section in the Surgery Branch. He has published over 280 peer reviewed journal articles, is Editor-in-Chief of the Nature Journal Cancer Gene Therapy, and holds seven U.S. patents. Clinical Expertise: Neuroendocrine tumors, thyroid cancer, parathyroid tumors, pancreatic cancer, liver cancer, gastrointestinal (GI) cancers, minimally invasive surgery, and clinical trials.
Regents Professor and Richards-Cohen Distinguished Chair in Clinical ResearchOsteopathic Research Center, University of North Texas Health Science Center
Clinical Research, Low Back Pain Research, low back pain guidelines, Preventive Medicine, public health and medicine
Dr. Licciardone’s research focuses on the prevention and treatment of chronic pain. He is the first recipient of a Regents Professorship awarded by the Texas College of Osteopathic Medicine since it was established 50 years ago. He also holds the Osteopathic Heritage Foundation Distinguished Chair in Clinical Research in honor of Drs. David Richards and Benjamin Cohen, former President and Provost of the University of North Texas Health Science Center. He presently directs the Osteopathic Research Center, including its PRECISION Pain Research Registry. The latter is the “first-in-the-nation” pain research registry, which studies precision medicine and biopsychosocial approaches to pain management. He received a Midcareer Investigator Award from the National Institutes of Health (NIH), served as an expert panelist for NIH in the area of chronic pain, and completed a four-year term on its National Advisory Council for Complementary and Integrative Health. He directed the OSTEOPATHIC Trial, a five-year study funded by NIH that demonstrated substantial improvements in and recovery from chronic low back pain with osteopathic manipulation. He is presently a Co-Investigator in the $14 million Prevention of Acute to Chronic Back Pain Trial (PACBACK Trial) sponsored by NIH, and recently served on the Work Group that developed NIH’s Federal Pain Research Strategy. Internationally, Dr. Licciardone has served as a consultant to the World Health Organization on regulatory and safety issues relating to osteopathy in Europe and other nations. He gave the keynote address at Advancing Osteopathy 2008, a conference celebrating the 10th anniversary of recognition of osteopaths in the United Kingdom’s National Health Service, including a preconference reception with His Royal Highness, The Prince of Wales. He has also met and advised two former United States Surgeons General on the role of osteopathic physicians within the American health care system. The American Osteopathic Foundation has honored Dr. Licciardone with its Gutensohn-Denslow Award for devoted lifetime service and contributions to research and education within the osteopathic profession.
Gary Liguori is a respected health expert with more than 25 years of experience as a university instructor, professor and researcher. He currently serves as the inaugural dean of the University of Rhode Island’s College of Health Sciences. Over the past 20 years, Liguori’s research on such topics as physical activity, nutrition, obesity, physical assessment and cardiac rehabilitation has been published widely in academic journals. As dean of the URI College of Health Sciences, Liguori oversees faculty, staff and students in seven departments: Communicative Disorders, Health Studies, Human Development and Family Studies, Kinesiology, Nutrition and Food Sciences, Physical Therapy and Psychology. The college enrolls approximately 3,000 undergraduate and 350 graduate students. He is also the coordinating dean of the University of Rhode Island Academic Health Collaborative, which includes the Colleges of Health Sciences, Nursing and Pharmacy, and the Institute for Integrated Health and Innovation, which fosters research, partnerships, and community engagement. In addition to serving as dean, Liguori is the senior editor of the upcoming 11th edition of the American College of Sports Medicine Guidelines for Exercise Testing and Prescription. He is also a USA Track & Field certified Level One track and field coach and a certified track and field meet official. Liguori is certified by the American College of Sports Medicine as a Clinical Exercise Physiologist, and by the American Heart Association to provide Advanced Cardiac Life Support. He also holds the credential of Advanced Physical Fitness Specialist from the Cooper Institute of Aerobics Research. Prior to joining URI in 2016, Liguori served as the head of the University of Tennessee Chattanooga Department of Health and Human Performance and was the founding director of its Healthy Living Center. From 2005 to 2012, Liguori was assistant/associate professor and graduate coordinator in the Department of Health, Nutrition & Exercise Sciences at North Dakota State University. Liguori earned his Ph.D. in wellness from the College of Human Development & Education at North Dakota State University and his master of science degree in cardiac rehabilitation/ exercise science from East Stroudsburg University.
LaShawnda Lindsay, Ph.D., is a research scientist at the Wellesley Centers for Women (WCW). Over the past decade, her research has created a platform that sheds light on the social determinants, racial injustices, and cultural biases that burden the progression and viability of Black girls and women. She has mentored Black girls, implemented sustainable programs and initiatives for Black girls, and most recently founded Black Girls Matter: A Social Media Campaign. Prior to joining WCW, Lindsay served as the interim chairperson and an associate professor of education at Paine College in Augusta, GA. Lindsay also uses her passion and creativity to enhance the wellbeing of girls and women by designing and creating her own line of jewelry and accessories, Ananse Design Essentials, LLC. This entrepreneurial endeavor and decade of research on/about/for black girls has promoted the creation of a new initiative, Black Girls Create (BGR). BGR is an informal STEM learning program that integrates fashion design and engineering to increase Black girls’ interest and value in STEM education and careers. Lindsay directs Black Girls Create, a culturally responsive STEM (science, technology, engineering, and math) program that uses digital fabrication projects to increase underserved girls' interest and confidence in science and math. The project builds on the notion that informal learning spaces can provide underserved students with access to quality STEM activities that are often unavailable in their schools. M.Ed., Counselor Education, Clinical Mental Health Counseling, Augusta University, December 2015 Ph.D., Educational Psychology, Georgia State University, May 2010 Graduate Certificate, Women’s Studies, Georgia State University, May 2009 M.Ed., Educational Psychology, Howard University, May 2003 B.S., Psychology, Morris Brown College, May 2001
Professor of Environmental StudiesBinghamton University, State University of New York
Anthroplogy, Environmental Studies, human population, Cultural Transmission, Remote Sensing, Geophysics
Lipo’s research interests include studying the cultural change of human populations. Lipo uses evolutionary theory as a means of developing methods for studying cultural transmission and the process of natural selection, acting on cultural systems. His work has explored community patterning among prehistoric potters of the Mississippi Valley, patterns of inheritance among stone tools producers in North America and the conditions that led the populations of Easter Island (Rapa Nui, Chili) to construct their famous monumental statues. In addition to the study of artifact variability and geochronology, Lipo has interests in remote sensing, as a means of efficiently and non-destructively studying the archaeological record. This work includes the use of magnetometry, resistivity, conductivity, thermal imagery, photogrammetry, LiDAR and ground penetrating radar.
Michelle Litchman, PhD, FNP-BC, FAANP, is an expert in diabetes care and using social media and other online resources to monitor how people with diabetes manage their own health in the real world. Litchman is an Assistant Professor at the College of Nursing and School of Medicine. Her position includes research, teaching, and clinical work at the Utah Diabetes and Endocrinology Center. She is passionate about teaching and precepts health sciences students and teaches didactic courses at the College of Nursing. Dr. Litchman’s program of research emphasizes the social context of chronic disease management across the lifespan with a particular emphasis on diabetes and technology. Her research examines online environments to understand the influence of peer support on health outcomes and diabetes management in the “real-world”. Dr. Litchman also examines family dynamics to understand how diabetes management is supported or derailed, and how technology might be helpful.
Kamala H. Littleton, M.D., is an expert orthopedic surgeon with Orthopedics and Joint Replacement at Mercy Medical Center in Baltimore, Maryland. Board Certified, Dr. Littleton specializes in joint replacement and reconstruction for the hip, knee and shoulder, including: Anterior hip replacement MAKO® knee resurfacing and knee replacement Minimally invasive total knee replacement ACL reconstruction Shoulder surgery and reconstruction Dr. Kamala Littleton is committed to providing her patients some of the best treatment options for their joint, hip, knee and shoulder pain. Dr. Littleton offers years of experience and specialized training to perform anterior hip replacement as well as MAKO knee resurfacing and knee replacement. These innovative orthopedic procedures enable her to help patients reduce their hip or knee pain so they can get back to normal daily activities. Dr. Kamala Littleton leads The Women’s Orthopedic Program at Mercy, which was developed to focus on the diagnosis and treatment of orthopedic conditions which most frequently affect women. Dr. Littleton recognizes that women have hormonal, anatomical and biomechanical characteristics that make them more vulnerable to certain orthopedic injuries and diseases. Some of the conditions more common to women include ACL tears, arthritis and osteoporosis. Prevention, treatment and avoiding reoccurrence are Dr. Littleton’s focus when treating women for their joint conditions. Her conservative approach coupled with her surgical expertise make her a top choice for patients seeking relief from hip, knee and shoulder pain.
Dr. Alexandra Lockwood is a Project Scientist at the Space Telescope Science Institute. She is the James Webb Space Telescope Communications Lead for the Institute and works on scientific storytelling to the general public on behalf of the mission. Previously she worked on the Joint Polar Satellite System and at the King Abdullah University of Science and Technology in Saudi Arabia, both in communications and outreach roles. Her dissertation was on planet formation in the near-infared, focusing on protoplanetary disks and direct detection of exoplanet atmospheres using high-resolution ground-based spectroscopy.
Losos is an internationally renowned scholar in the field of evolutionary biology. In partnership with the Missouri Botanical Garden and the St. Louis Zoo, Losos leads the Living Earth Collaborative, an academic center dedicated to advancing the study of biodiversity. The Living Earth Collaborative serves as a hub to facilitate interdisciplinary research among plant and animal biologists and other scholars across a wide range of fields, bringing together the world’s leading scholars in the field of biodiversity to address the most pressing issue facing humankind today — the ability to sustain life on Earth.
Paul R. Lucas, M.D., is an experienced vascular surgeon and Director of The Vascular Center at Mercy in Baltimore, Maryland. He is Board Certified in Vascular Surgery and has been recognized as a Top Doc by Baltimore magazine numerous times. Dr. Lucas leads a team of vascular surgeons and technologists who specialize in the diagnosis and treatment of patients with diseased blood vessels. His patients admire his attentive and caring professionalism and he is noted for taking the time to be sure they understand their condition and treatment options. Dr. Paul Lucas utilizes the latest technologies to care for patients experiencing vascular disorders. He specializes in Venefit™ (formerly known as VNUS Closure™) and Veingogh© procedures for varicose vein removal and is continuously seeking advanced diagnostic and treatment options for more efficient care. Dr. Paul Lucas is a Registered Physician in Vascular Interpretation and was instrumental in the establishment of Mercy's nationally accredited Vascular Laboratory at The Vascular Center at Mercy. Patients can be screened at all of Mercy’s physician office locations throughout Greater Baltimore, making diagnosis and subsequent scheduling for treatment convenient. Using non-invasive Doppler ultrasound equipment, lab technologists screen patients for circulatory problems like mini-strokes, circulation issues, leg swelling or pain, blood clots and aneurysms.